FDA
-
-
-
-
-
-
-
Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD
-
-
-
-
-
-
-
Recapitalisation Led by Sophisticated Life Sciences Investor - Apeiron Investment Group Ltd
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

